Kim Hwan Il, Moon Seong Mi, Oh Hyo Seok, Ko Ryoung-Eun
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Republic of Korea.
Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea.
Pulm Ther. 2025 Sep 18. doi: 10.1007/s41030-025-00317-y.
Neutropenia is a common clinical condition in critically ill patients and may be associated with poor outcomes, particularly in the context of acute respiratory failure (ARF). However, evidence on its prognostic impact remains inconsistent, and there are a lack of data, particularly in noncancer and immunocompetent populations. This study evaluates the association between neutropenia and mortality in critically ill patients with ARF and identifies risk factors for mortality among patients with neutropenia.
In this retrospective cohort study, 2412 adult patients with ARF admitted to the intensive care unit (ICU) of a tertiary center between January 2019 and December 2023 were analyzed. Neutropenia was defined as an absolute neutrophil count < 1.5 × 10⁹/L at ICU admission. The primary outcome was hospital mortality; secondary outcomes included ICU mortality. Multivariable Cox proportional hazards models were used to assess the association between neutropenia and outcomes. Subgroup analyses and risk factor assessments were conducted among patients with neutropenia.
Among the 2412 patients, 411 (17.0%) had neutropenia at ICU admission. Compared with their counterparts without neutropenia, patients with neutropenia had higher ICU mortality (48.0% versus 18.9%, P < 0.001) and hospital mortality (60.1% versus 28.3%, P = 0.007). Neutropenia remained independently associated with increased ICU (adjusted hazard ratio [HR] 1.48; 95% confidence interval [CI], 1.20-1.83) and hospital mortality (adjusted HR 1.27; 95% CI 1.07-1.52). The association was more pronounced in patients without cancer (adjusted HR 3.08) than in patients with cancer (adjusted HR 1.48; P for interaction < 0.001). Among patients with neutropenia, sequential organ failure assessment (SOFA) score was an independent predictor of hospital mortality (adjusted HR 1.15; 95% CI 1.11-1.20; P < 0.001).
Neutropenia at ICU admission is independently associated with increased mortality in patients with ARF, particularly among those without cancer. SOFA score is a strong prognostic indicator among patients with neutropenia. These findings highlight the need for improved risk stratification, and suggest that patients with neutropenia may benefit from specific management strategies, which should be investigated in future studies.
中性粒细胞减少是危重症患者常见的临床情况,可能与不良预后相关,尤其是在急性呼吸衰竭(ARF)的背景下。然而,关于其预后影响的证据仍然不一致,并且缺乏数据,特别是在非癌症和免疫功能正常的人群中。本研究评估了ARF危重症患者中性粒细胞减少与死亡率之间的关联,并确定了中性粒细胞减少患者的死亡危险因素。
在这项回顾性队列研究中,分析了2019年1月至2023年12月期间入住三级中心重症监护病房(ICU)的2412例成年ARF患者。中性粒细胞减少定义为ICU入院时绝对中性粒细胞计数<1.5×10⁹/L。主要结局是医院死亡率;次要结局包括ICU死亡率。使用多变量Cox比例风险模型评估中性粒细胞减少与结局之间的关联。对中性粒细胞减少患者进行亚组分析和危险因素评估。
在2412例患者中,411例(17.0%)在ICU入院时存在中性粒细胞减少。与无中性粒细胞减少的患者相比,中性粒细胞减少患者的ICU死亡率更高(48.0%对18.9%,P<0.001),医院死亡率更高(60.1%对28.3%,P=0.007)。中性粒细胞减少仍然与ICU死亡率增加(调整后风险比[HR]1.48;95%置信区间[CI],1.20-1.83)和医院死亡率增加(调整后HR 1.27;95%CI 1.07-1.52)独立相关。这种关联在非癌症患者中(调整后HR 3.08)比在癌症患者中(调整后HR 1.48;交互作用P<0.001)更为明显。在中性粒细胞减少患者中,序贯器官衰竭评估(SOFA)评分是医院死亡率的独立预测因素(调整后HR 1.15;95%CI 1.11-1.20;P<0.001)。
ICU入院时的中性粒细胞减少与ARF患者死亡率增加独立相关,尤其是在非癌症患者中。SOFA评分是中性粒细胞减少患者的一个强有力的预后指标。这些发现强调了改进风险分层的必要性,并表明中性粒细胞减少患者可能从特定的管理策略中获益,这应在未来的研究中进行调查。